Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7902237 Heterocyclic compounds as pharmaceutical agents

Patent 7902237 was granted and assigned to Exelixis on March, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 27 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 27 Nov, 2023
Edits made to:
Article (+368 characters)
Article

Patent abstract

Compounds, compositions and methods for modulating the activity of receptors are provided. In particular, compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of the disease or disorder directly or indirectly related to the activity of the receptors.

Edits on 19 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 19 Sep, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Brenton Todd Flatt0
Jeffrey Dean Kahl0
Richard Martin0
Edits on 15 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 15 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07902237 Heterocyclic compounds as pharmaceutical agents US Patent 7902237 Heterocyclic compounds as pharmaceutical agents

Infobox
Patent Number
079022370
Patent Number
79022370
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=079022370
Edits on 29 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Exelixis
Exelixis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
079022370
Date of Patent
March 8, 2011
0
Patent Application Number
115736140
Date Filed
August 9, 2005
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=079022370
Patent Primary Examiner
‌
Golam M. Shameem
0
Edits on 4 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 4 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07902237
Edits on 7 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 7 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07902237 Heterocyclic compounds as pharmaceutical agents

Infobox
Is a
Patent
Patent
Current assignee
Exelixis
Exelixis
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07902237
Date of patent
March 8, 2011
Patent application number
11573614
Date Filed
August 9, 2005
Patent primary examiner
‌
Golam M. Shameem

Find more entities like US Patent 7902237 Heterocyclic compounds as pharmaceutical agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.